Jb Chemicals

• 

  J B Chemicals Up 12%, Hits Fresh 52-Week High On Strong December Quarter

  JB Chemicals' earnings before interest, taxes, depreciation and amortization (EBITDA) or operating profit climbed 90 per cent

• 

  JB Chemicals Soars 3% After Stake Purchase By KKR

  KKR JB Chemicals: The global investment firm KKR said that it entered into a definitive agreement to purchase a controlling stake of 54 per cent in the Mumbai-based pharma company.

• 

  Trading Calls: Buy L&T Finance Holdings, Tata Global, Adani Ports, Say Experts

  Indian shares opened on a flat note on Wednesday, tracking lacklustre note global cues. Trader's sentiment remained cautious ahead of the state election result announcement on Saturday.

• 

  JB Chemicals & Pharmaceuticals Q2 Net Jumps 7%

  The company had posted a net profit of Rs 42.14 crore during the same period a year ago, JB Chemicals & Pharmaceuticals said in a filing to BSE.

• 

  JB Chemicals Q4 Net Up 68% To Rs 43 Crore

  JB Chemicals & Pharmaceuticals on Friday posted a 67.97 per cent rise in net profit at Rs 43.22 crore for the fourth quarter ended March 31.

• 

  Will Challenge Green Tribunal Order to Close Gujarat Plant: JB Chemicals

  JB Chemicals & Pharmaceuticals on Wednesday said it will challenge in the Supreme Court an order by the National Green Tribunal (NGT) which has directed closure of its bulk drugs plant at Panoli, Gujarat within a month.

• 

  Buy JB Chemicals, KCP Sugar, Styrolution ABS: G Chokkalingam

  G Chokkalingam, founder of Equinomics Research & Advisory, says that the markets have recently started to perform well, with the FIIs investing in four out of six days since the historic rate hike by the Federal Reserve on December 16.

• JB Chemicals & Pharmaceuticals Q1 Net Up 8% at Rs 34 Crore

  Standalone net sales of the company also rose to Rs 279.14 crore for the quarter under consideration as against Rs 256.71 crore for the year-ago period.

• JB Chemicals posts net loss of Rs 6.47 crore in Q3

  JB Chemicals & Pharmaceuticals on Tuesday posted a net loss of 6.47 crore for the third quarter that ended in December 2013.

• Midcap stocks that outperformed in 2013

  The BSE's mid-cap and small-cap indices fell by about 10 per cent and 16 per cent, respectively, in 2013. However, there have been some pockets of strength even in the broader markets.

• JB Chemicals Q4 net rises over two-fold to Rs 20 crore

  JB Chemicals & Pharmaceuticals Ltd said on Friday that its net profit surged over two-fold to Rs 19.75 crore for the fourth quarter ended March 31, 2013.

• DR.REDDY'S LABORATORIES LTD. - Dr Reddy's acquires prescription business of JB Chemicals & Pharmaceuticals in Russia & other CIS markets

  Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated July 22, 2011 titled "Dr Reddy's acquires prescription business of JB Chemicals & Pharmaceuticals in Russia & other CIS markets".

• JB Chemicals & Pharmaceuticals Ltd - Notice of Postal Ballot

  JB Chemicals & Pharmaceuticals Ltd has informed BSE that the members of the Company will consider to approve the resolution by way of Postal Ballot.

• JB Chemicals & Pharmaceuticals Ltd - Fixes Book Closure for Dividend & AGM

  JB Chemicals & Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 18, 2011 to July 25, 2011 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company.

• JB Chemicals & Pharmaceuticals Ltd - Outcome of Board Meeting - J. B. Chemicals & Pharmaceuticals Limited to sell its Russia/OS Over-The-Counter Busin

  JB Chemicals & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2011, inter alia, has approved sale of the company's Russia/CIS OTC business to Cilag GmbH International. The Company has submitted to BSE a copy of release relating the relevant details of the transaction approved.